logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Clinical Pharmacokinetics 封面图

Clinical Pharmacokinetics

IF4
论文数242
被引数11244
期刊论文 242
发表时间
delete
Microbiome-Mediated Pharmacokinetics and Informed Dosing of Mycophenolate in Kidney Transplantation微生物组介导的霉酚酸在肾移植中的药代动力学与指导剂量
deleteClinical Pharmacokinetics
IF4
delete2026-10-28
delete0
deleteOAAI
deleteAbdelrahman Saqr; Moataz E. Mohamed; Christopher Staley; Guillaume Onyeaghala; Duy Vo; Rory P. Remmel; Levi Teigen; Weihua Guan; William S. Oetting; Rasha El-Rifai; Casey R. Dorr; Kajal Gupta; Arthur J. Matas; Ajay K. Israni; Pamala A. Jacobson
delete分享
delete收藏
Paediatric Fentanyl Population Pharmacokinetics: A Scoping Review of Published Models儿科芬太尼群体药代动力学：已发表模型的范围综述
deleteClinical Pharmacokinetics
IF4
delete2026-10-27
delete0
deleteOAAI
deleteJosephine J. Hughes; Gi Kon Nam; Michael A. Stokes; Indy Sandaradura; Marino S. Festa; Sophie L. Stocker
delete分享
delete收藏
Once-Weekly Insulin Icodec: A Review of its Pharmacokinetic and Pharmacodynamic Properties每周一次胰岛素icodec：对其药代动力学和药效学特性的综述
deleteClinical Pharmacokinetics
IF4
delete2026-10-26
delete0
deleteOAAI
deleteT. Heise; M. P. Haridas; N. R. Kristensen; C. Mathieu; R. Ribel-Madsen; T. R. Pieber
delete分享
delete收藏
The Predictive Value of Gastrin for the Absorption of Erlotinib in Patients with Non-Small Cell Lung Cancer胃泌素对非小细胞肺癌患者厄洛替尼吸收的预测价值
deleteClinical Pharmacokinetics
IF4
delete2026-10-23
delete0
deleteOAAI
deleteNiels Heersche; Daan A. C. Lanser; Sophie M. Ernst; Cornelis Kramers; Marthe S. Paats; Anne-Marie C. Dingemans; Ron H. N. van Schaik; Ron H. J. Mathijssen; G. D. Marijn Veerman
delete分享
delete收藏
The Variability in the Pharmacokinetics of Follitropin Alfa: A Systematic Review重组促卵泡激素α的药代动力学变异性：一项系统综述
deleteClinical Pharmacokinetics
IF4
delete2026-10-22
delete0
deleteOAAI
deleteRanita Kirubakaran; Toni J. F. Michael; Beverley J. Vollenhoven; Vinayak Smith; Sophie L. Stocker
delete分享
delete收藏
Population Pharmacokinetic/Pharmacodynamic Analysis of HHT120, a Novel Direct Thrombin Inhibitor, in Healthy Participants from a Phase I Clinical TrialHHT120这一新型直接凝血酶抑制剂在健康受试者中的药代动力学/药效动力学分析：一项I期临床试验
deleteClinical Pharmacokinetics
IF4
delete2026-10-22
delete0
PREAI
deleteQingyu Yao; Xue Zhou; Yaou Liu; Jingyi Feng; Ran Xie; Runfeng Lin; Yongxing Wang; Qin Huang; Ying Zhou
delete分享
delete收藏
A Patient-Centered Approach for Drug–Drug Interaction (DDI) Assessment: Integrating Nested Clinical DDI Studies to Verify Translatability of Healthy Volunteer DDI Data, Minimize Stand-Alone Trials, and Enrich Drug Labeling以患者为中心的药物-药物相互作用（DDI）评估方法：整合嵌套临床DDI研究以验证健康志愿者DDI数据的可转化性，减少独立试验，并丰富药物标签
deleteClinical Pharmacokinetics
IF4
delete2026-10-21
delete0
PREAI
deleteCheuk Fung Chan; Young Sun Scaringella; Fenglei Huang
delete分享
delete收藏
Clinical Pharmacokinetics of Polmacoxib (CG100649): A Tissue-Selective Dual COX-2 and Carbonic Anhydrase I/II Inhibitor波尔马昔布（CG100649）的临床药代动力学：一种组织选择性双效COX-2和碳酸酐酶I/II抑制剂
deleteClinical Pharmacokinetics
IF4
delete2026-10-15
delete0
PREAI
deleteMarlon C. Mallillin; Md Harunur Rashid; Yasmin Abouelbaqa; Kamal Dua; Raimar Löbenberg; Neal M. Davies
delete分享
delete收藏
Efsubaglutide Alfa: A Comprehensive Pharmacological ReviewEfsubaglutide Alfa：一份全面的药理学综述
deleteClinical Pharmacokinetics
IF4
delete2026-10-13
delete0
PREAI
deleteHaolin Zheng; Run Yan; Fan Jiang; Yi Li; Gerald J. Prud’homme; Qinghua Wang
delete分享
delete收藏
Physiologically Based Pharmacokinetic Modeling of Elexacaftor–Tezacaftor–Ivacaftor in Adults and Pediatric People with Cystic Fibrosis: Exploring Brain Exposure and Neuropsychiatric Adverse Events基于生理的药代动力学模型在囊性纤维化成人和儿科患者中研究Elexacaftor–Tezacaftor–Ivacaftor的脑部暴露和神经精神不良事件
deleteClinical Pharmacokinetics
IF4
delete2026-10-09
delete0
PREAI
deleteClotilde Vellat; Laurent Bourguignon; Sabine Cohen; Philippe Reix; Romain Garreau
delete分享
delete收藏
Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review药代动力学模型在新生儿、婴儿和幼儿精确给药中的应用：一项范围综述
deleteClinical Pharmacokinetics
IF4
delete2026-10-07
delete0
deleteOAAI
deleteAna S. Rodríguez-Báez; Nina Kreuzberger; Claire Iannizzi; Kamran Irfan; Frederike Lentz; Anna Krueger; Norbert Benda; Ulrich Jaehde
delete分享
delete收藏
Assessing the Influence of CYP3A4 Inhibitors on Voriconazole Exposure across CYP2C19 Genotypes: A Physiologically Based Pharmacokinetic Model Analysis评估CYP3A4抑制剂对Voriconazole暴露的影响：基于生理药代动力学模型的分析
deleteClinical Pharmacokinetics
IF4
delete2026-10-07
delete0
PREAI
deleteSahithi Thotakura; Anil R. Maharaj
delete分享
delete收藏
Pharmacokinetics of Efavirenz in Pregnancy and Postpartum with and Without First-line Tuberculosis Drugs: Results from IMPAACT P1026s妊娠及产后期间使用和不使用一线结核病药物时依非韦伦的药代动力学：IMPAACT P1026s研究结果
deleteClinical Pharmacokinetics
IF4
delete2026-10-03
delete0
deleteOAAI
deleteMarije Van Schalkwyk; Jiajia Wang; Adrie Bekker; Eric Decloedt; Gerhard B. Theron; Mark F. Cotton; Tim R. Cressey; Deo Wabwire; Chelsea Stotz; Kevin Knowles; Kathleen George; Renee Browning; Kittipong Rungruengthanakit; Lubbe Wiesner; Edmund V. Capparelli; Alice M. Stek; Mark Mirochnick; David E. Shapiro; Brookie M. Best; Ahizechukwu C. Eke
delete分享
delete收藏
The Effect of Intrinsic Factors on the Pharmacokinetics of Once-Weekly Insulin Icodec in Type 1 and Type 2 Diabetes: A Population Pharmacokinetic Analysis of Phase II and Phase III trials一性和二性糖尿病中胰岛素Icodec每周一次给药的药代动力学受内在因素的影响：基于II期和III期试验的人群药代动力学分析
deleteClinical Pharmacokinetics
IF4
delete2026-09-30
delete0
deleteOAAI
deleteNiels R. Kristensen; Mundot P. Haridas; Athena Philis-Tsimikas; Rasmus Ribel-Madsen; Chantal Mathieu
delete分享
delete收藏
Optimization of Cefotaxime Treatment in Intensive Care Patients: Impact of Inter- and Intra-patient Variability on Pharmacokinetics and Target Attainment优化头孢噻肟在重症监护患者中的治疗方案：患者间及患者内变异性对药代动力学和目标达成的影响
deleteClinical Pharmacokinetics
IF4
delete2026-09-30
delete0
PREAI
deleteAnthéa Deschamps; Florence Gattacceca; Olivier Blin; Lionel Velly; Romain Guilhaumou
delete分享
delete收藏
Structured Evaluation of Model-Informed Precision Dosing of Mycophenolic Acid and Tacrolimus in Pediatric Patients with Kidney Disease基于模型指导的霉酚酸和他克莫司在肾病患者儿科患者中精准给药的结构化评价
deleteClinical Pharmacokinetics
IF4
delete2026-09-30
delete0
deleteOAAI
deleteAstrid Heida; Elisabeth A. M. Cornelissen; Rob E. Aarnoutse; Brenda C. M. de Winter; Ron J. Keizer; Rob ter Heine; Nynke G. L. Jager
delete分享
delete收藏
Understanding Pharmacokinetic Variability of Pomalidomide: A Physiologically Based Pharmacokinetic Analysis of Disease-Related Physiology, Ethnicity, Hepatic Impairment, Food Effects, Drug Interactions, and Smoking理解泊马利多米德的药代动力学变异性：基于生理学的药代动力学分析，探讨疾病相关生理、种族、肝功能损害、食物影响、药物相互作用和吸烟的影响
deleteClinical Pharmacokinetics
IF4
delete2026-09-30
delete0
deleteOAAI
deleteJeffry Adiwidjaja; Alan V. Boddy; Andrew J. McLachlan
delete分享
delete收藏
Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels瑞格列奈药代动力学在射血分数降低的心力衰竭患者中的影响：对瑞格列奈和生长分化因子-15血浆水平的影响
deleteClinical Pharmacokinetics
IF4
delete2026-09-28
delete0
deleteOAAI
deleteAnders Hostrup Larsen; Tore Bjerregaard Stage; Mette Marie Hougaard Christensen; Søren Feddersen; Flemming Nielsen; Helene Nørrelund; Jørgen Frøkiær; Niels Jessen; Kim Brøsen; Henrik Wiggers
delete分享
delete收藏
Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients比较机器学习模型与一种新开发的儿童患者硫代嘌呤类药物群体药代动力学模型的预测性能
deleteClinical Pharmacokinetics
IF4
delete2026-09-22
delete0
deleteOAAI
deleteTianwu Yang; Maria Thastrup; Tania Nicole Masmas; Hilde Hylland Uhlving; Jacob Nersting; Malene Johanne Petersen; Anna Sofie Buhl Rasmussen; Kjeld Schmiegelow; Trine Meldgaard Lund
delete分享
delete收藏
PBPK Modeling of Coproporphyrin I Reveals Frailty-Associated Changes in Hepatic OATP1B1 Function in Chinese AdultsPBPK模型对粪卟啉I的建模揭示了中国成年人肝OATP1B1功能与脆弱性相关的变化
deleteClinical Pharmacokinetics
IF4
delete2026-09-21
delete0
PREAI
deleteLongjie Li; Mengfan Ye; Wenhang Xu; Xinyan Zhu; Like Xie; Haiping Xu; Qingfeng He; Xiao Zhu; Xiaoqiang Xiang; Juan Xie
delete分享
delete收藏